SLC12A8 mediates TKI resistance in EGFR-mutant lung cancer via PDK1/AKT axis. Huang F, Cui J, Wan J, Yuan X, et al. J Cancer Res Clin Oncol 2023 Sep 19. doi: 10.1007/s00432-023-05416.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Huang F, Cui J, Wan J, Yuan X, et al. SLC12A8 mediates TKI resistance in EGFR-mutant lung cancer via PDK1/AKT axis. J Cancer Res Clin Oncol 2023 Sep 19. doi: 10.1007/s00432-023-05416.
PMID: 37725242